FABP4 and metabolic syndrome: Previous studies also showed that the serum A-FABP level predicts the development of metabolic syndrome [10] and was associated with carotid intima-media thickness [11], the number of stenotic coronary arteries [12], and coronary plaque volume determined by intravascular ultrasound (IVUS) [13].